FINNENCE ▪ THE WIRE FILE
THE WIRE · № 57257
Company■ Unclear/unknown
Phase 3 results posted: A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases — Takeda
KINDCompany
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-09-30 12:00 UTC
LAST UPDATE2026-09-30 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Completed Phase 3 results for TAK-881 in primary immunodeficiency are posted without efficacy detail in the text.
Trial completion, outcome details absent
CATALYST TO WATCH
Full data readout or filing
MAIN RISK
Results content not summarized here
FULL DISPATCH
Sponsor: Takeda; Status: Completed; Conditions: Primary Immunodeficiency Diseases (PID); Interventions: TAK-881, HYQVIA; Enrollment: 65 (actual); First posted: 2023-03-06; Results posted: 2026-09-30; NCT: NCT05755035
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
New Phase 3b data show Lilly's EBGLYSS (lebrikizumab-lbkz) delivered significant and rapid improvements in skin clearance, itch, pain, and patient satisfaction in people with moderate-to-severe hand and foot atopic dermatitis2026-09-30 12:03 UTC
New Phase 3b data show Lilly's EBGLYSS (lebrikizumab-lbkz) delivered significant and rapid improvements in skin clearance, itch, pain, and patient satisfaction in people with moderate-to-severe hand and foot atopic dermatitis2026-09-30 12:03 UTC
→CORRELATIONshares Healthcare
HealthPartners and Essentia Health Propose Major Merger2026-09-30 12:56 UTC
HealthPartners and Essentia Health Propose Major Merger2026-09-30 12:56 UTC
→CORRELATIONshares Healthcare
Masimo Wins Two OCTANE High Tech Awards - Company Recognized for 'Deal of the Year' and 'Best Technology Leadership Team'2026-09-30 13:05 UTC
Masimo Wins Two OCTANE High Tech Awards - Company Recognized for 'Deal of the Year' and 'Best Technology Leadership Team'2026-09-30 13:05 UTC
←CORRELATIONshares Healthcare
Union, governor’s office strike deal on state employee healthcare costs2026-09-29 22:54 UTC
Union, governor’s office strike deal on state employee healthcare costs2026-09-29 22:54 UTC
←CORRELATIONshares Healthcare
The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities2026-09-30 11:00 UTC
The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities2026-09-30 11:00 UTC
←CORRELATIONshares Healthcare
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care2026-09-30 11:00 UTC
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care2026-09-30 11:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.